Status:

ACTIVE_NOT_RECRUITING

A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Collaborating Sponsors:

M.D. Anderson Cancer Center

Brigham and Women's Hospital

Conditions:

Multiple Ground Glass Opacities (GGOs)

Eligibility:

All Genders

19+ years

Brief Summary

The purpose of this registry study is to actively monitor people with GGOs and collect information about them, so that investigators can learn more about these lesions and about the risk of developing...

Eligibility Criteria

Inclusion

  • Age greater than 18 years
  • Have two or more GGOs on initial CT imaging
  • GGOs must be measure ≤3.0 cm and ≥0.6 cm in the greatest dimension
  • GGOs must be greater than half ground glass
  • A biopsy is not necessary for inclusion in the trial. Biopsy of a GGO, even with a diagnosis of adenocarcinoma, does not necessarily preclude enrollment in this surveillance protocol. In other words, patients with a diagnosis of adenocarcinoma are still eligible, at the discretion of the clinician and/or investigator, if they meet the above criteria.

Exclusion

  • Patients who are actively undergoing lung cancer treatment or have a history of lung cancer, except for cases of completely resected pathologic stage IA nonsmall cell lung cancer (NSCLC). Patients with stage IA NSCLC and multiple GGOs can enroll in this active surveillance protocol after complete resection of the NSCLC and confirmation of stage on final pathologic assessment.
  • The presence of any solid lesion ≥0.6 cm suspicious for malignancy.
  • Patients who are actively undergoing treatment for other malignancies

Key Trial Info

Start Date :

January 9 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2026

Estimated Enrollment :

338 Patients enrolled

Trial Details

Trial ID

NCT03802981

Start Date

January 9 2019

End Date

January 1 2026

Last Update

December 23 2025

Active Locations (32)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (32 locations)

1

University of California San Diego

San Diego, California, United States, 92103

2

Stanford University Medical Center (Data collection only)

Stanford, California, United States, 94305-5408

3

Hartford Healthcare

Hartford, Connecticut, United States, 06102

4

Rush University Medical Center (Data collection only)

Chicago, Illinois, United States, 606012